Contact
Please use this form to send email to PR contact of this press release:
Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients
TO:
Please use this form to send email to PR contact of this press release:
Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients
TO: